TargED Biopharmaceuticals Revenue

Pharmaceutical Manufacturing • Utrecht, Utrecht, Netherlands • 21-50 Employees

TargED Biopharmaceuticals revenue & valuation

Annual revenue	$2,823,315
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$9,100,000
Total funding	$55,800,000

Key Contacts at TargED Biopharmaceuticals

Marc Van Moorsel

Co-Founder & Director Of Operations

Marielle Klein Hesselink

Medical Director

Marel De Wit

Senior Director Regulatory Affairs

Company overview

Headquarters	Princetonlaan 6, Utrecht, 3584 CB, NL
Websites	targedbiopharmaceuticals.com targedbio.com
NAICS	3254
Keywords	Biologicals, Thrombolysis, Microvascular Thrombosis
Founded	2018
Employees	21-50
Socials

TargED Biopharmaceuticals Email Formats

TargED Biopharmaceuticals uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@targedbio.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@targedbio.com	100%

About TargED Biopharmaceuticals

TargED started in September 2018 and is currently developing one biopharmaceutical product: MICROLYSE. MICROLYSE enzymatically breaks down blood clots in small blood vessels (i.e. the microvasculature), for which to date, no specific treatment exists. TargED pursues to receive market authorization for an orphan disease named Thrombotic Thrombocytopenic Purpura (TTP) that is characterized by life threatening attacks of microvascular thrombosis. However, MICROLYSE has the capacity to target all forms of microvascular thrombosis and could also be applied in early-stage macrovascular thrombosis as seen in heart attacks and stroke.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

TargED Biopharmaceuticals has 12 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore TargED Biopharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-03-19	4	$44,200,000
2025-07-24	1	$11,600,000

Funding Insights

$55,800,000

Total funding amount

$11,600,000

Most recent funding amount

Number of funding rounds

TargED Biopharmaceuticals Tech Stack

Discover the technologies and tools that power TargED Biopharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Gravity Forms

Form builders

Swiper

JavaScript libraries

Google Maps

Maps

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Yoast SEO

SEO

Priority Hints

Performance

Nginx

Reverse proxies

core-js

JavaScript libraries

RSS

Miscellaneous

Frequently asked questions

TargED Biopharmaceuticals is located in Utrecht, Utrecht, NL.

TargED Biopharmaceuticals generates an estimated annual revenue of $2,823,315. This revenue figure reflects the company's market position and business performance in its industry.

TargED Biopharmaceuticals has an estimated valuation of $9,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

TargED Biopharmaceuticals was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

TargED Biopharmaceuticals has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

TargED Biopharmaceuticals has raised a total of $55,800,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at TargED Biopharmaceuticals

Marc Van Moorsel

Co-Founder & Director Of Operations

Marielle Klein Hesselink

Medical Director

Marel De Wit

Senior Director Regulatory Affairs

4.8

40,000 users